IP Library Granted Patent US 12,427,097
Granted Patent B2
US 12,427,097 · App. 18/886,244 · Granted Sep 30, 2025

Oral care compositions comprising monodentate and polydentate ligand

Inventors: William Michael Glandorf (Mason, OH); Andrew Frederic Groth (Mason, OH); Samuel James St. John (Cincinnati, OH); Ross Strand (Singapore, SG)
Assignee: The Procter & Gamble Company
A61K8/27A61K8/06A61K8/21A61K8/25A61K8/29A61K8/362A61K8/365A61K8/37A61K8/55A61K8/60A61K8/73A61Q11/00A61K2800/48A61K2800/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,427,097
App. No.
18/886,244
Granted
Sep 30, 2025
Kind
B2
Abstract

Oral care compositions including tin, monodentate ligand, and polydentate ligand with an optimized molar ratio of tin to monodentate ligand to polydentate ligand. Oral care compositions with a tin to monodentate ligand to polydentate molar ratio of from about 1:0.5:0.5 to about 1:5:5. Oral care compositions including tin, monocarboxylic acid, and tricarboxylic acid.

Claims (22)

1. An oral care composition comprising:

(a) tin, wherein the tin comprises stannous fluoride, stannous chloride, or combinations thereof;

(b) monodentate ligand, wherein the monodentate ligand comprises a compound comprising a single functional group capable of chelating tin, and wherein the monodentate ligand comprises carboxylic acid or a salt thereof, wherein the carboxylic acid comprises aliphatic carboxylic acid, sugar acid, salts thereof, or combinations thereof;

(c) polydentate ligand, wherein the polydentate ligand comprises a compound comprising at least two functional groups capable of chelating tin, wherein the polydentate ligand comprises a bidentate ligand and/or a tridentate ligand, and wherein the polydentate ligand comprises carboxylic acid, phosphate, polyphosphate, or combinations thereof, wherein the carboxylic acid comprises dicarboxylic acid, tricarboxylic acid, salts thereof, or combinations thereof; and

(d) a fluoride source,

wherein the oral care composition has a tin to monodentate ligand to polydentate ligand molar ratio of 1:1:1 to 1:2.5:2.5.

2. The oral care composition of claim 1 , wherein the sugar acid comprises aldonic acid, ulsonic acid, uronic acid, aldaric acid, salts thereof, or combinations thereof.

3. The oral care composition of claim 2 , wherein the sugar acid comprises gluconate.

4. The oral care composition of claim 1 , wherein the aliphatic carboxylic acid comprises linear saturated carboxylic acid, linear unsaturated carboxylic acid, alpha hydroxy acid, beta hydroxy acid, gamma hydroxy acid, amino acid, salts thereof, or combinations thereof.

5. The oral care composition of claim 4 , wherein the amino acid comprises glycine, alanine, valine, isoleucine, tryptophan, phenylalanine, proline, methionine, leucine, serine, threonine, tyrosine, asparagine, glutamine, cysteine, citrulline, aspartic acid, glutamic acid, lysine, arginine, histidine, or combinations thereof.

6. The oral care composition of claim 4 , wherein the alpha hydroxy acid comprises lactate.

7. The oral care composition of claim 1 , wherein the phosphate comprises inorganic phosphate salt, organophosphate, or combinations thereof.

8. The oral care composition of claim 7 , wherein the phosphate salt comprises orthophosphate, hydrogen phosphate, dihydrogen phosphate, or combinations thereof.

9. The oral care composition of claim 1 , wherein the dicarboxylic acid comprises a compound with the formula HO2C-R-CO2H, wherein R is aliphatic, aromatic, or combinations thereof.

10. The oral care composition of claim 1 , wherein the dicarboxylic acid comprises oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azerlaic acid, sebacic acid, undecanedioic acid, dodecanedioic acid, brassylic acid, thapsic acid, japanic acid, phellogenic acid, equisetolic acid, salts thereof, or combinations thereof.

11. The oral care composition of claim 1 , wherein the tricarboxylic acid comprises citric acid, isocictric acid, aconitic acid, propane-1,2,3-tricarboxylic acid, trimesic acid, salts thereof, or combinations thereof.

12. The oral care composition of claim 1 , wherein the polyphosphate comprises pyrophosphate, tripolyphosphate, tetrapolyphosphate, hexametaphosphate, or combinations thereof.

13. The oral care composition of claim 1 , wherein the composition comprises zinc.

14. The oral care composition of claim 13 , wherein the zinc comprises zinc citrate, zinc lactate, zinc oxide, zinc phosphate, or combinations thereof.

15. The oral care composition of claim 1 , wherein the oral care composition comprises no added water, or comprises water.

16. The oral care composition of claim 15 , wherein the oral care composition comprises up to 45%, by weight of the composition, of water.

17. The oral care composition of claim 1 , wherein the oral care composition comprises a dentifrice composition, a unit-dose oral care composition, an emulsion composition, or a leave-on oral care composition.

Continuity (3)
Continuation 17308081 · May 5, 2021
Provisional Application 63020032 · May 5, 2020
Related Publication 20250009616A1 · Jan 9, 2025
References Cited (67)
US 3105798A · Holliday · 1963 [cited by examiner]
US 4902497A · Crisanti · 1990 [cited by applicant]
US 6350436B1 · Glandorf et al. · 2002 [cited by applicant]
US 6555094B1 · Glandorf et al. · 2003 [cited by applicant]
US 6685920B2 · Baig · 2004 [cited by applicant]
US 6696045B2 · Yue · 2004 [cited by applicant]
US 6714309B2 · May · 2004 [cited by applicant]
US 7387774B2 · Faller · 2008 [cited by applicant]
US 8795637B2 · Deckner et al. · 2014 [cited by applicant]
US 8906347B2 · Strand · 2014 [cited by applicant]
US 9155769B2 · Hoke et al. · 2015 [cited by applicant]
US 9687427B2 · Li et al. · 2017 [cited by applicant]
US 10172770B2 · Rege · 2019 [cited by applicant]
US 10213368B2 · Li et al. · 2019 [cited by applicant]
US 10214368B2 · Demers · 2019 [cited by applicant]
US 10258549B2 · Baig · 2019 [cited by applicant]
US 10258550B2 · Baig · 2019 [cited by applicant]
US 10357438B2 · Jaracz · 2019 [cited by applicant]
US 10369090B2 · Baig · 2019 [cited by applicant]
US 10376451B2 · Baig · 2019 [cited by applicant]
US 10470985B2 · Baig · 2019 [cited by applicant]
US 10548827B2 · Hodgkinson · 2020 [cited by applicant]
US 10596086B2 · Ramji et al. · 2020 [cited by applicant]
US 10646417B2 · Mcgill · 2020 [cited by applicant]
US 20020106336A1 · Glandorf · 2002 [cited by applicant]
US 20080286214A1 · Brown · 2008 [cited by applicant]
US 20080311055A1 · Futterer · 2008 [cited by applicant]
US 20110020246A1 · Strand · 2011 [cited by applicant]
US 20110020247A1 · Strand · 2011 [cited by applicant]
US 20110020248A1 · Strand · 2011 [cited by applicant]
US 20120219606A1 · Deckner · 2012 [cited by examiner]
US 20120276023A1 · Shimohirao · 2012 [cited by applicant]
US 20140037555A1 · Hoke, II · 2014 [cited by applicant]
US 20140127145A1 · Deckner · 2014 [cited by applicant]
US 20140227202A1 · Pilgaonkar · 2014 [cited by applicant]
US 20170105911A1 · Budde · 2017 [cited by applicant]
US 20170157171A1 · Gerard · 2017 [cited by applicant]
US 20170333310A1 · Subramanyam · 2017 [cited by applicant]
US 20170367939A1 · Thomson et al. · 2017 [cited by applicant]
US 20170367948A1 · Thomson et al. · 2017 [cited by applicant]
US 20180235853A1 · Brown et al. · 2018 [cited by applicant]
US 20190209448A1 · Dogu et al. · 2019 [cited by applicant]
US 20190298636A1 · Strand · 2019 [cited by applicant]
US 20200170902A1 · Ramji et al. · 2020 [cited by applicant]
US 20200188264A1 · Hodgkinson · 2020 [cited by applicant]
US 20200405593A1 · Baig et al. · 2020 [cited by applicant]
US 20200405594A1 · Baig et al. · 2020 [cited by applicant]
US 20200405595A1 · Gupta et al. · 2020 [cited by applicant]
US 20210346252A1 · Baig et al. · 2021 [cited by applicant]
US 20210346253A1 · Baig et al. · 2021 [cited by applicant]
US 20210346255A1 · Glandorf et al. · 2021 [cited by applicant]
US 20210346256A1 · Baig et al. · 2021 [cited by applicant]
CN 104069013A · 2014 [cited by applicant]
EP 2057978A1 · 2009 [cited by applicant]
EP 2281543A1 · 2011 [cited by applicant]
WO 2007076001A2 · 2007 [cited by applicant]
WO 2019183876A1 · 2019 [cited by applicant]
First Office Action; Chinese Patent Application No. 202180033288.0 dated Jul. 27, 2023; 12 pages. [cited by applicant]
Notice of Allowance; Chinese Patent Application No. 202180033288.0 dated May 30, 2024; 3 pages. [cited by applicant]
Office Action; Chinese Patent Application No. 202180033288.0 dated Jan. 8, 2024; 12 pages. [cited by applicant]
PCT Search Report and Written Opinion for PCT/US2021/030754 dated Oct. 11, 2021, 12 pages. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/308,081, filed May 5, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/308,083, filed May 5, 2021. [cited by applicant]
All Office Actions; U.S. Appl. No. 17/308,085, filed May 5, 2021. [cited by applicant]
Deep Clean Fluoride Toothpaste, Mintel, Retrieved from Internet: http://www.gndp.com, Aug. 13, 2018, 4 pages. [cited by applicant]
Lolontika Hoque, “This is why you shouldn't swallow your toothpaste (besides it being totally disgusting), Spoon University, online retrieved from https://spoonuniversity.com/lifestyle/can-you-eat-toothpaste-this-is-why… [cited by applicant]
Sensitive Protect Smooth Mint Toothpaste, Mintel, Retrieved from Internet: http://www.gndp.com, Nov. 28, 2019, 4 pages. [cited by applicant]